Targeted therapies: Doxorubicin and sorafenib improves survival in patients with advanced hepatocellular carcinoma

Nature Reviews Clinical Oncology

Volumn 8, Issue 2, 2011, Pages 61-

  Hutchinson, Lisa ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

DOXORUBICIN; SORAFENIB;

ADVANCED CANCER; CANCER SURVIVAL; HUMAN; INOPERABLE CANCER; LIVER CELL CARCINOMA; METASTASIS POTENTIAL; NOTE; PRIORITY JOURNAL; PROGNOSIS;

EID: 79551609767     PISSN: 17594774     EISSN: 17594782     Source Type: Journal    
DOI: 10.1038/nrclinonc.2010.208     Document Type: Note

References (1)

1. Abou-Alfa, G. K. et al. Doxorubicin plus sorafenib vs doxorubicin alone in patients with advanced hepatocellular carcinoma. JAMA 304, 2154-2160 (2010)